FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Berwick Donald M 		2. Issuer Name and Ticker or Trading Symbol

NATIONAL RESEARCH CORP [ NRCIA/B ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

4/17/2018
(Street)

LINCOLN, NE 68508
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   (1) 4/17/2018     A (2)    5090   A   (2) 5090   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Stock Option (Right to Buy)   $32.09   4/17/2018     D         6000      (2) 10/21/2025   Class B Common Stock   6000     (2) 0   D    
Director Stock Option (Right to Buy)   $37.78   4/17/2018     D         6000      (2) 5/11/2026   Class B Common Stock   6000     (2) 0   D    
Director Stock Option (Right to Buy)   $44.47   4/17/2018     D         6000      (2) 5/9/2027   Class B Common Stock   6000     (2) 0   D    
Director Stock Option (Right to Buy)   $15.19                    10/21/2016   10/21/2025   Common Stock   36000     36000   D    
Director Stock Option (Right to Buy)   $14.19                    5/11/2017   5/11/2026   Common Stock   36000     36000   D    
Director Stock Option (Right to Buy)   $24.35                    5/9/2018   5/9/2027   Common Stock   36000     36000   D    

Explanation of Responses:
(1)  On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization").
(2)  Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Berwick Donald M
C/O NATIONAL RESEARCH CORPORATION
1245 Q STREET
LINCOLN, NE 68508 		X



Signatures
/s/ Russell E. Ryba, Attorney-in-Fact for Donald M. Berwick 4/18/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
National Research Corp. (delisted) (NASDAQ:NRCIB)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more National Research Corp. (delisted) Charts.
National Research Corp. (delisted) (NASDAQ:NRCIB)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more National Research Corp. (delisted) Charts.